4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Quorum sensing system in Acinetobacter baumannii : a potential target for new drug development

      1 , 1 , 2 , 3
      Journal of Applied Microbiology
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acinetobacter baumannii causes several nosocomial infections and poses major threat when it is multidrug resistant. Even pan drug-resistant strains have been reported in some countries. The intensive care unit (ICU) mortality rate ranged from 45.6% to 60.9% and it is as high as 84.3% when ventilator-associated pneumonia was caused by XDR (extensively drug resistant) A. baumannii. Acinetobacter baumannii constituted 9.4% of all Gram-negative organisms throughout the hospital and 22.6% in the ICUs according to a study carried out in an Indian hospital. One of the major factors contributing to drug resistance in A. baumannii infections is biofilm development. Quorum sensing (QS) facilitates biofilm formation and therefore the search for 'quorum quenchers' has increased recently. Such compounds are expected to inhibit biofilm formation and hence reduce/prevent development of drug resistance in the bacteria. Some of these compounds also target synthesis of some virulence factors (VF). Several candidate drugs have been identified and are at various stages of drug development. Since quorum quenching, inhibition of biofilm formation and inhibition of VF synthesis do not pose any threat to the DNA replication and cell division of the bacteria, chances of resistance development to such compounds is presumably rare. Thus, these compounds ideally qualify as adjunct therapeutics and could be administered along with an antibiotic to reduce chances of resistance development and also to increase the effectiveness of antimicrobial therapy. This review describes the state-of-art in QS process in Gram-negative bacteria in general and in A. baumannii in particular. This article elaborates the nature of QS mediators, their characteristics, and the methods for their detection and quantification. Various potential sites in the QS pathway have been highlighted as drug targets and the candidate quorum quenchers which inhibit the mediator's synthesis or function are enlisted.

          Related collections

          Author and article information

          Journal
          Journal of Applied Microbiology
          J Appl Microbiol
          Wiley
          1364-5072
          1365-2672
          May 18 2019
          May 18 2019
          Affiliations
          [1 ]Department of Molecular Diagnostics & Biomarkers, Global Medical Education & Research Foundation (GMERF) Global Towers 6‐1‐82/83Lakdi‐ka‐pul, Hyderabad
          [2 ]Global Medical Education & Research Foundation (GMERF) Global Towers 6‐1‐82/83Lakdi‐ka‐pul, Hyderabad
          [3 ]Department of Molecular Diagnostics & Biomarkers Gleneagles Global Hospital Global Medical Education & Research Foundation (GMERF) Global Towers & Secretary6‐1‐82/83Lakdi‐ka‐pulHyderabad India
          Article
          10.1111/jam.14330
          31102552
          1f2fe7c9-2aad-450f-b20d-902c8294e28d
          © 2019

          http://doi.wiley.com/10.1002/tdm_license_1.1

          History

          Comments

          Comment on this article